Novavax
FinanceModerna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says ‘wishes subservient confirmation of his misinformation and lies’
By Sasha RogelbergMarch 31, 2025
By Lindsey LeakeSeptember 30, 2024
HealthNew COVID vaccines are here. What to know about latest shots in wake of nation’s biggest summer surge
By Lindsey LeakeAugust 29, 2024
HealthA COVID-vaccine maker received $1.6 billion in Operation Warp Speed funding. It’s administered just 7,300 shots in the U.S.
By Nicholas GordonAugust 9, 2022
HealthA ‘breadth of protection’: Novavax’s newly approved COVID vaccine arms the U.S. with a new weapon against Omicron BA.5 subvariant
By Grady McGregorJuly 14, 2022
By Lauran Neergaard and The Associated PressJune 2, 2022
HealthNovavax stock continues its monthslong slide even after COVID vaccine earns approval in another country
By Eamon BarrettApril 19, 2022
HealthIndia is the first country to approve the Novavax vaccine for teens, as the world readies for another COVID wave
By Nicholas GordonMarch 23, 2022
HealthThe weird case of Novavax’s falling stock price: The vaccine that might be big news for the vax hesitant
By Andrew MarquardtMarch 15, 2022
HealthSingapore is the latest country to approve Novavax’s COVID vaccine while the U.S. reviews application
By Grady McGregorFebruary 14, 2022
HealthNovavax’s newest approvals position it as an mRNA ‘alternative’ that health officials say may convince vaccine skeptics
By Grady McGregorFebruary 4, 2022
By Grady McGregorJanuary 27, 2022
By Grady McGregorJanuary 19, 2022
Most Popular
